Sol Gel Ownership
| SLGL Stock | USD 1.05 0.06 5.41% |
Shares in Circulation | First Issued 2016-09-30 | Previous Quarter 27.9 M | Current Value 27.9 M | Avarage Shares Outstanding 21.5 M | Quarterly Volatility 4.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Sol |
Sol Stock Ownership Analysis
About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.84. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sol Gel Technologies recorded a loss per share of 0.34. The entity had not issued any dividends in recent years. Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel. Sol-Gel Technologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 53 people. To find out more about Sol Gel Technologies contact Alon SeriLevy at 972 8 931 3433 or learn more at https://www.sol-gel.com.Besides selling stocks to institutional investors, Sol Gel also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Sol Gel's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Sol Gel's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Sol Gel Quarterly Liabilities And Stockholders Equity |
|
About 65.0% of Sol Gel Technologies are currently held by insiders. Unlike Sol Gel's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Sol Gel's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Sol Gel's insider trades
Sol Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sol Gel is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sol Gel Technologies backward and forwards among themselves. Sol Gel's institutional investor refers to the entity that pools money to purchase Sol Gel's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Two Sigma Securities, Llc | 2024-09-30 | 25.9 K | Geode Capital Management, Llc | 2024-09-30 | 13.4 K | Xtx Topco Ltd | 2024-09-30 | 10.9 K | Cetera Investment Advisers | 2024-09-30 | 10.5 K | Steward Partners Investment Advisory, Llc | 2024-09-30 | 4.2 K | Ubs Group Ag | 2024-09-30 | 3.5 K | Blackrock Inc | 2024-09-30 | 3.1 K | Bank Of America Corp | 2024-09-30 | 2.4 K | Simplex Trading, Llc | 2024-06-30 | 726 | Phoenix Financial Ltd | 2024-09-30 | 2.5 M | Migdal Insurance & Financial Holdings Ltd | 2024-09-30 | 1.2 M |
Sol Gel Outstanding Bonds
Sol Gel issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sol Gel Technologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sol bonds can be classified according to their maturity, which is the date when Sol Gel Technologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| International Game Technology Corp BondUS460599AD57 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Sol Gel Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sol Gel. If investors know Sol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sol Gel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.34) | Revenue Per Share | Quarterly Revenue Growth 8.146 | Return On Assets | Return On Equity |
The market value of Sol Gel Technologies is measured differently than its book value, which is the value of Sol that is recorded on the company's balance sheet. Investors also form their own opinion of Sol Gel's value that differs from its market value or its book value, called intrinsic value, which is Sol Gel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sol Gel's market value can be influenced by many factors that don't directly affect Sol Gel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sol Gel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sol Gel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sol Gel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.